Evaro
A digital health startup that offers AI-powered clinical and drug prescription services for minor conditions
Evaro has raised €22M across 2 funding rounds from 6 investors, most recently a Series A round in Jan 2026. Based in London, UK; active in Healthtech. Data as of 28 Oct 2026.
London, UKevaro.com ↗
Total raised
€22M
€22,341,478
Funding rounds
2
Investors
6
distinct backers
Active since
2024-01
latest 2026-01
Funding by year
EUR raised per year · 2026 YTDEvaro — funding by year — interactive chart.
Data table
| Evaro — funding by year | |
|---|---|
| 2024 | €1.4M |
| 2026 | €21M |
Signals
High confidenceRaise-next likelihood49
base rate 44% for Series A
- ▲ In typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood15
base rate 11% (2+ rounds)
- ▼ Young (<3y)
- ▲ Recently backed by strong-exit-track investors
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-01-27 | Series A | €21M | British Business Investments (BBI),Cornerstone VC,Exceptional Ventures,Simplyhealth Ventures | View deal → |
| 2024-01-31 | Seed | €1.4M | Cornerstone VC,Exceptional Ventures,Syndicate Room,the University of East Anglia | View deal → |